ARCHIVES

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

This article is from The Cancer Letter archive.

Vol. 27 No. 26 | June 29, 2001

Download PDF Visit The Full Archive

Related Articles

Massive New Radiation Research program Costing From $300-$400 Million Over 10 Years Suggested

February 11, 1977

Smokeless Tobacco Consensus Conference Slates in Health Risks

August 16, 1985

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials

December 31, 2010

Funding opportunities listed.

January 2, 2004

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012